药物再利用中的创新策略,以应对细胞内细菌病原体
Blanca Lorente-Torres1, Jesús Llano-Verdeja1, Pablo Castañera1
1Departamento de Biología Molecular, Área de Microbiología, Universidad de León, 24071 León, Spain.
Antibiotics (Basel, Switzerland)
|September 28, 2024
概括
药物再利用提供了一种有前途的策略,通过确定现有药物的新用途来对抗细胞内细菌感染. 这种方法利用已有的药物来克服细菌耐药性并增强对具有挑战性的病原体的免疫反应.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 细胞内细菌病原体由于免疫规避和抗生素耐药性而带来重大公共卫生挑战.
- 传统的治疗方法往往对这些有弹性的微生物无效.
- 药物再利用是一种新兴的策略,用于确定现有药物的新疗法应用.
研究的目的:
- 探索药物重用在开发细胞内细菌感染新疗法的潜力.
- 审查对细胞内细菌有效的现有药物.
- 讨论识别和验证重用药物的方法.
主要方法:
- 高通量选 高通量选 高通量选
- 生物信息学分析.
- 系统生物学方法.系统生物学方法.
- 现有研究的文献综述.
主要成果:
- 一些现有的药物,包括神经乱药 (thioridazine,chlorpromazine),抗癌药物 (tamoxifen,imatinib),他类药物和抗炎药物,显示出潜在的疗效.
- 重用药物表现出多种机制,例如诱导自和增强宿主免疫反应.
- 已识别的药物对*黄金葡萄球菌*,*单细胞菌菌*和*结核菌菌*等病原体表现出有效性.
结论:
- 药物再利用是开发针对细胞内细菌的新型抗微生物疗法的可行和有前途的战略.
- 这种方法解决了对抗药物耐药细菌感染的有效治疗的迫切需要.
- 进一步的研究和验证对于将这些发现转化为临床实践至关重要.
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Antibiotic Selection
52.4K
Overview
52.4K
Lytic Cycle of Bacteriophages
70.4K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.4K
Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K


